Skip to main content

Table 2 Comparison of patients’ intraoperative and postoperative conditions treated by the three different strategies (n = 51)

From: Clinical analysis of second-trimester pregnancy termination after previous caesarean delivery in 51 patients with placenta previa and placenta accreta spectrum: a retrospective study

items

mifepristone + misoprostol

mifepristone + Rivanol

hysterotomy

p

 

(n = 16)

(n = 14)

(n = 21)

 

Bleeding volume in 24 h of surgery(mL)

672.50 ± 673.42

528.57 ± 610.08

752.38 ± 1310.58

0.626b

Rescue rate (n,%)

11(68.8)

8(57.1)

8(38.1)

0.168c

Blood transfusion rate (n,%)

6(37.5)

2(14.3)

4(19.0)

0.268c

Hysterectomy rate (n, %)

0(0)

1(7.1)

3(14.3)

0.286c

Main operative success rate (n,%)

5(31.3)

5(35.7)

18(85.7)

0.001c

Hospital stay(d)

10.69 ± 4.38

12.79 ± 8.40

11.57 ± 3.11

0.795b

Blood β-hCG decline of 3rd days after treatment (%)

92.79 ± 8.81

91.96 ± 8.33

91.85 ± 6.55

0.354b

Time of β-hCG recovery (d)

40.06 ± 1.56*

37.21 ± 2.39

32.95 ± 1.79*

0.028a

Time of menstrual recovery (d)

54.13 ± 2.67

55.50 ± 5.05

48.24 ± 4.03

0.195b

Residual placenta

   

0.739c

Expecting treatment

3(18.8)

4(28.6)

3(15.0)

 

Medical treatment

10(62.5)

6(42.9)

10(50.0)

 

Surgical treatment

3(18.8)

4(28.6)

7(35.0)

 
  1. Data are presented as mean ± SD and count (%)
  2. aOne-way analysis of variance, brank sum test of multiple independent samples, c χ2 test. *Bonferroni adjustment p < 0.017